SEC Filing Summary: Prestige Brands Holdings, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed on November 8, 2005, by Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.). The filing addresses the issuance of a press release regarding second-quarter results and fiscal 2006 guidance, as well as a critical determination to restate prior financial statements due to accounting errors.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1) and the forthcoming amended filings (10-Q/A and 10-K/A).
Material Changes and Restatement
The Company has determined that previously issued financial statements for the years ended March 31, 2005, 2004, and 2003, as well as quarterly data for the years ended March 31, 2005 and 2004, should no longer be relied upon. This decision follows a review of accounting policies and procedures which identified errors in:
- Revenue Recognition: Erroneous application of Staff Accounting Bulletin 104 regarding revenue recognition upon shipment of products.
- Trade Promotion Allowances: Improper classification of certain allowances under Emerging Issues Task Force Issue 01-09.
- Earnings Per Share (EPS): Incorrect inclusion of unvested, restricted common shares in EPS computations under Statement of Financial Accounting Standards No. 128.
An independent review was conducted with the assistance of independent counsel and forensic accountants. The Company plans to file amended Form 10-Q/A for the quarter ended June 30, 2005, and amended Form 10-K/A for the year ended March 31, 2005, as soon as practicable.
Guidance, Outlook, and Risks
The Company issued a press release on November 15, 2005, containing earnings guidance for fiscal 2006 and details on the restatement. The primary risk identified is the material misstatement of historical financial data, which necessitates a restatement and a loss of reliance on prior reports. The Audit Committee and management have discussed these findings with the independent auditor, PricewaterhouseCoopers LLP.
Investor Verification Checklist
- Verify the specific financial impact of the restatement on revenue and net income once the amended 10-Q/A and 10-K/A are filed.
- Review the attached press release (Exhibit 99.1) for the detailed table summarizing the restatement effects.
- Confirm the revised earnings guidance for fiscal 2006 provided in the November 15, 2005 press release.
- Monitor for any further disclosures regarding the internal controls review or additional accounting adjustments.